<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>2. Pathological Jaundice</title>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <link rel="stylesheet" href="../styles/main.css">
    <!-- Include MathJax -->
    <script>
    MathJax = {
        tex: {
            inlineMath: [['$', '$'], ['\\(', '\\)']],
            displayMath: [['$$', '$$'], ['\\[', '\\]']],
            processEscapes: true,
            processEnvironments: true,
            tags: 'ams' // Use AMS numbering of equations
        },
        svg: { fontCache: 'global' },
        options: {
            skipHtmlTags: ['script', 'noscript', 'style', 'textarea', 'pre']
        }
    };
    </script>
    <script src="https://polyfill.io/v3/polyfill.min.js?features=es6"></script>
    <script id="MathJax-script" async src="https://cdn.jsdelivr.net/npm/mathjax@3/es5/tex-mml-chtml.js"></script>
</head>
<body>
    <div class="container">
        <article class="document-section" role="main">
            <!-- Top Navigation -->
            <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="01-introduction-and-physiology.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 4</span>
                    </div>
                    <a href="03-kernicterus-and-clinical-features.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

            <header class="section-header">
                <h1 class="section-title">Pathological Jaundice</h1>
                <div class="title-underline"></div>
            </header>

            <main class="section-content">
                
                <section id="pathological-unconjugated-hyperbilirubinemia" class="content-section" aria-labelledby="section-heading-18">
                    <h2 id="section-heading-18" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">PATHOLOGICAL Unconjugated hyperbilirubinemia</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>$\uparrow$ bilirubin load metabolized by liver</li>
                            <li>Damaged/ $\downarrow$ transferase enzyme activity</li>
                            <li>Competition and blocking transferase enzyme</li>
                        </ul>
                    </div>
                </section>

                <section id="increased-bilirubin-load" class="content-section" aria-labelledby="section-heading-19">
                    <h2 id="section-heading-19" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">$\uparrow$ bilirubin load</span>
                    </h2>
                    <div class="content-card">
                        <p><strong>A) Hemolytic anemia</strong></p>
                        <ul>
                            <li>-immune-</li>
                            <li>Rhesus isoimmunization</li>
                            <li>Most severe degree of hyperbilirubinaemia</li>
                            <li>First baby is not affected</li>
                            <li>Develops within the first few hours of life</li>
                            <li>Rise of bilirubin occur rapidly within 48 hours</li>
                            <li>Cholestasis may occur due to congestion of the liver from extramedullary erythropoisis, heart failure and from tissue hypoxia due to decreased blood supply and anaemia</li>
                            <li>High risk of encephalopathy</li>
                            <li>RX-phototherapy,exchange transfusion,anti D to mother</li>
                        </ul>
                        <p><strong>Scenario 2</strong></p>
                        <p><strong>Pathological Jaundice Secondary to Rh Incompatability</strong></p>
                        <img src="../assets/images/2025_09_02_1bc465bb9c73bf4afa7cg-029-1.jpg" alt="Diagram explaining Rh incompatibility between an Rh-negative mother and an Rh-positive fetus, leading to hemolytic disease of the newborn." class="content-image">
                        <img src="../assets/images/2025_09_02_1bc465bb9c73bf4afa7cg-030-1.jpg" alt="Illustration showing the mechanism of ABO incompatibility, another cause of hemolytic jaundice in newborns." class="content-image">
                        <ul>
                            <li>ABO incompatibility
                                <ul>
                                    <li>Milder and more brief</li>
                                    <li>Rarely causes kernicterus</li>
                                    <li>Occur even in first born</li>
                                    <li>Common in blood group O mother and group A baby</li>
                                </ul>
                            </li>
                            <li>Inheritable -
                                <ul>
                                    <li>RBC membrane defects
                                        <ul>
                                            <li>e.g hereditary spherocytosis,elliptocytosis</li>
                                        </ul>
                                    </li>
                                    <li>RBC enzyme deficiences
                                        <ul>
                                            <li>glucose 6 phosphate deficiencies,pyruvate kinase deficiency</li>
                                        </ul>
                                    </li>
                                    <li>hemoglobinophathies</li>
                                </ul>
                            </li>
                            <li>Others
                                <ul>
                                    <li>Sepsis-infection increases RBC destruction and hepatocellular damage</li>
                                    <li>Extravasation of blood-hematoma, pulmonary haemorrage -this slows bilirubin release as macrophages gradually converts heme to bilirubin</li>
                                </ul>
                            </li>
                        </ul>
                        <p><strong>в) increased enterohepatic circulation</strong></p>
                        <ul>
                            <li>Breast milk jaundice
                                <ul>
                                    <li>develops in an estimated 2% of breastfed term infants</li>
                                    <li>after the 7th day of life, with maximal concentrations as high as $10-30 \mathrm{mg} / \mathrm{dL}$</li>
                                    <li>reached during the $2 \mathrm{nd}-3 \mathrm{rd}$ week.</li>
                                    <li>If breast-feeding is continued, the bilirubin gradually decreases</li>
                                    <li>may persist for $3-10 \mathrm{wk}$ at lower levels.</li>
                                    <li>Phototherapy may be of benefit.</li>
                                    <li>etiology of breast-milk jaundice is not entirely clear</li>
                                    <li>may be attributed to the presence of glucuronidase in some breast milk.</li>
                                </ul>
                            </li>
                            <li>Breastfeeding jaundice
                                <ul>
                                    <li>occur in the 1st week of life</li>
                                    <li>Hyperbilirubinemia ($>12 \mathrm{mg} / \mathrm{dL}$) develops in 13% of breast-fed infants in the 1st wk of life</li>
                                </ul>
                            </li>
                        </ul>
                    </div>
                </section>
                
                <section id="aetiology" class="content-section" aria-labelledby="section-heading-20">
                    <h2 id="section-heading-20" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Aetiology</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>may be due to
                                <ul>
                                    <li>decreased milk intake with dehydration</li>
                                    <li>and/or reduced caloric intake.</li>
                                </ul>
                            </li>
                            <li>Giving supplements of glucose water to breast-fed infants is associated with higher bilirubin levels,
                                <ul>
                                    <li>in part because of reduced intake of the higher caloric density of breast milk.</li>
                                </ul>
                            </li>
                            <li>Frequent breast-feeding ($>10 / 24 \mathrm{hr}$)</li>
                            <li>rooming-in with night feeding</li>
                            <li>discouraging 5% dextrose or water supplementation</li>
                            <li>lactation support</li>
                        </ul>
                        <p><small>* Gourley, GR, Arend, RA. beta-Glucuronidase and hyperbilirubinaemia in breast-fed and formula-fed babies. Lancet 1986; 1:644.</small></p>
                        <ul>
                            <li>Intestinal disorders-
                                <ul>
                                    <li>Pyloric stenosis</li>
                                    <li>Small or large bowel obstruction</li>
                                    <li>Reduces clearance of bilirubin due to increased enterohepatic circulation</li>
                                </ul>
                            </li>
                            <li>If nursing is discontinued, the serum bilirubin level falls rapidly, reaching normal levels within a few days.</li>
                            <li>With resumption of breast-feeding, bilirubin levels seldom</li>
                        </ul>
                        <p><strong>C) decreased clearance</strong></p>
                        <ul>
                            <li>prematurity</li>
                            <li>congenital atresia of the bile ducts.</li>
                            <li>Jaundice persisting for more than 2 wk</li>
                            <li>associated with acholic stools and dark urine</li>
                            <li>inspissated bile syndrome.</li>
                        </ul>
                        <p><strong>D) Metabolic disorders</strong></p>
                        <ul>
                            <li>Hypothyroidism- prolonged jaundice occurs in $10 \%$ of cases</li>
                            <li>Results from depressed metabolism or dependance of maturition of hepatic pathways on thyroxine</li>
                            <li>Hypopituitarism</li>
                        </ul>
                        <p><strong>E) In born errors of metabolism</strong> galactosemia tyrosinemia</p>
                    </div>
                </section>

                <section id="transferase-enzyme-activity" class="content-section" aria-labelledby="section-heading-21">
                    <h2 id="section-heading-21" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Damaged / $\downarrow$ transferase enzyme activity</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Genetic deficiencies $\rightarrow$ absent /deficient enzymes</li>
                        </ul>
                        <h3>Genetic</h3>
                        <p><strong>1. Familial disorders of conjugation e.g.</strong></p>
                        <ul>
                            <li>
                                <strong>Gilbert's syndrome-</strong>
                                <ul>
                                    <li>affect enzyme encoding</li>
                                    <li>autosomal dominant and recessive</li>
                                    <li>Usually mild</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Criglar-Nagger I-</strong>
                                <ul>
                                    <li>inherited</li>
                                    <li>Autosomal recessive</li>
                                    <li>Infants have a complete absence of UDPGT</li>
                                    <li>Develop severe jaundice</li>
                                    <li>RX liver transplant</li>
                                </ul>
                            </li>
                            <li>
                                <strong>Crigler najjar type ii</strong>
                                <ul>
                                    <li>Autosomal dominant</li>
                                    <li>Less severe</li>
                                    <li>Neonates with reduced enzyme activity</li>
                                    <li>Respond to phenobarbitone</li>
                                </ul>
                            </li>
                        </ul>
                        <ol>
                            <li>Enzymatic defects-G6PD;pyruvate kinase;hexokinase; congenital erythropoietic porphyria</li>
                            <li>Erythrocyte structural defects-spherocytes;elliptocytes</li>
                        </ol>
                        <ul>
                            <li>Hypoxia</li>
                            <li>Hypothermia-decreased enzyme activity</li>
                        </ul>
                    </div>
                </section>

                <section id="competition-and-blocking-transferase-enzyme" class="content-section" aria-labelledby="section-heading-22">
                    <h2 id="section-heading-22" class="section-heading">
                        <span class="heading-icon"> </span>
                        <span class="heading-text">Competition and blocking transferase enzyme</span>
                    </h2>
                    <div class="content-card">
                        <ul>
                            <li>Drugs and other substances requiring glucuronic acid oxidation</li>
                        </ul>
                    </div>
                </section>

            </main>

            <!-- Bottom Navigation -->
             <nav class="document-nav" role="navigation" aria-label="Document Sections">
                <div class="nav-links">
                    <a href="../index.html" class="nav-button">
                        <span class="nav-icon"></span>
                        <span class="nav-text">Table of Contents</span>
                    </a>
                    <a href="01-introduction-and-physiology.html" class="nav-button">
                        <span class="nav-icon">←</span>
                        <span class="nav-text">Previous Section</span>
                    </a>
                    <div class="document-progress">
                         <div class="progress-bar" aria-hidden="true">
                            <div class="progress-fill" style="width: 50%;"></div>
                        </div>
                       <span class="progress-text">Lecture 2 of 4</span>
                    </div>
                    <a href="03-kernicterus-and-clinical-features.html" class="nav-button">
                        <span class="nav-text">Next Section</span>
                        <span class="nav-icon">→</span>
                    </a>
                </div>
            </nav>

        </article>
    </div>
    <script src="../js/navigation.js"></script>
</body>
</html>